Home › Pancreatic Ductal Carcinoma › Ohio › Cincinnati
Pancreatic Ductal Carcinoma clinical trials in Cincinnati, OH
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 2
- Site 13, Cincinnati
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- University of Cincinnati Medical Center, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- Christ Hospital Cancer Center, Cincinnati
Pancreatic Ductal Carcinoma trials in other cities
- Boston, MA4 studies
- Nashville, TN4 studies
- Scottsdale, AZ3 studies
- Houston, TX3 studies
- Orange, CA3 studies
- San Antonio, TX3 studies
- Arlington, VA3 studies
- Tampa, FL3 studies
- New York City, NY3 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)27 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Metastatic Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer19 studies
- Obesity19 studies
- Lung Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.